Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).

Attar A, Mirhosseini SA, Mathur A, Dowlut S, Monabati A, Kasaei M, Abtahi F, Kiwan Y, Vosough M, Azarpira N

DOI: 10.1136/bmj-2024-083382
Published: 2025 Oct 29
Container: BMJ (Clinical research ed.)
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmj-2024-083382,
  title = {Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).},
  author = {Attar A and Mirhosseini SA and Mathur A and Dowlut S and Monabati A and Kasaei M and Abtahi F and Kiwan Y and Vosough M and Azarpira N},
  year = {2025},
  journal = {BMJ (Clinical research ed.)},
  doi = {10.1136/bmj-2024-083382},
  url = {https://doi.org/10.1136/bmj-2024-083382}
}

RIS

TY  - JOUR
TI  - Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
AU  - Attar A
AU  - Mirhosseini SA
AU  - Mathur A
AU  - Dowlut S
AU  - Monabati A
AU  - Kasaei M
AU  - Abtahi F
AU  - Kiwan Y
AU  - Vosough M
AU  - Azarpira N
PY  - 2025
JO  - BMJ (Clinical research ed.)
DO  - 10.1136/bmj-2024-083382
UR  - https://doi.org/10.1136/bmj-2024-083382
ER  -

APA

A, A., SA, M., A, M., S, D., A, M., M, K., F, A., Y, K., M, V., & N, A. (2025). Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).. BMJ (Clinical research ed.). https://doi.org/10.1136/bmj-2024-083382

Source records

pubmed · retrieved 2026-11-10T12:39:41.072Z